India to United States: Dextromethorphan Export Trade Route
India has recorded 143 verified shipments of Dextromethorphan exported to United States, representing a combined trade value of $3.5M USD. This corridor is served by 22 active Indian exporters, with an average shipment value of $24.4K USD. The leading Indian exporter is ELYSIUM PHARMACEUTICALS LTD, which accounts for 26% of total export value with 20 shipments worth $903.9K USD. On the buying side, PRODOSE INC. is the largest importer in United States with $559.6K USD in purchases. The top 3 suppliers — ELYSIUM PHARMACEUTICALS LTD, DR.REDDY'S LABORATORIES LTD, ELYSIUM PHARMACEUTICALS LIMITED — together control 46% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Dextromethorphan corridor is one of India's established pharmaceutical export routes, with 143 shipments documented worth a combined $3.5M USD. The route is dominated by ELYSIUM PHARMACEUTICALS LTD, which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's dextromethorphan manufacturing sector.
Across 22 active suppliers, the average shipment value stands at $24.4K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with dextromethorphan's non-urgent bulk-order profile.
Shipment activity peaks during July–September, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 22.2%, placing it at rank #4 among India's top dextromethorphan export destinations globally.
On the import side, key buyers of Indian dextromethorphan in United States include PRODOSE INC., SPIRIT PHARMACEUTICALS LLC, SHIELD PHARMACEUTICALS CORP. and 29 others. PRODOSE INC. is the single largest importer with 10 shipments valued at $559.6K USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ3
- Primary modeSea freight
- Top portDADRI ICD (INDER6)
Market Position
- Global rank#4
- Annual growth+22.2%
- Demand growth+18.9%
- Regulatory ease89/100
Top 10 Indian Dextromethorphan Exporters to United States
Showing top 10 of 22 Indian suppliers exporting Dextromethorphan to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ELYSIUM PHARMACEUTICALS LTD Avg $45.2K per shipment | 20 | $903.9K | 25.9% |
| 2 | DR.REDDY'S LABORATORIES LTD Avg $21.7K per shipment | 18 | $391.4K | 11.2% |
| 3 | ELYSIUM PHARMACEUTICALS LIMITED Avg $49.7K per shipment | 6 | $298.3K | 8.5% |
| 4 | OCEAN HEALTHCARE PRIVATE LIMITED Avg $37.2K per shipment | 8 | $297.7K | 8.5% |
| 5 | ALDER BIOCHEM PRIVATE LIMITED Avg $10.2K per shipment | 25 | $255.7K | 7.3% |
| 6 | AUROBINDO PHARMA LIMITED Avg $51.8K per shipment | 4 | $207.0K | 5.9% |
| 7 | ANAGHA PHARMACEUTICALS PRIVATE LIMITED Avg $91.6K per shipment | 2 | $183.2K | 5.2% |
| 8 | SUN PHARMACEUTICAL INDUSTRIES LIMITED Avg $58.7K per shipment | 3 | $176.0K | 5.0% |
| 9 | DR.REDDY'S LABORATORIES LIMITED Avg $24.6K per shipment | 6 | $147.6K | 4.2% |
| 10 | SIMZEN PHARMACHEM PRIVATE LIMITED Avg $39.0K per shipment | 3 | $117.0K | 3.3% |
This table shows the top 10 of 22 Indian companies exporting dextromethorphan to United States, ranked by total trade value. The listed exporters are: ELYSIUM PHARMACEUTICALS LTD, DR.REDDY'S LABORATORIES LTD, ELYSIUM PHARMACEUTICALS LIMITED, OCEAN HEALTHCARE PRIVATE LIMITED, ALDER BIOCHEM PRIVATE LIMITED, AUROBINDO PHARMA LIMITED, ANAGHA PHARMACEUTICALS PRIVATE LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR.REDDY'S LABORATORIES LIMITED, SIMZEN PHARMACHEM PRIVATE LIMITED. ELYSIUM PHARMACEUTICALS LTD is the dominant supplier with 20 shipments worth $903.9K USD, giving it a 26% market share. The top 3 suppliers together account for 46% of the total trade value on this route.
Showing top 10 of 22 total Indian exporters on the India to United States Dextromethorphan export route.
Top 10 Dextromethorphan Importers in United States
Showing top 10 of 32 known buyers in United States receiving Dextromethorphan shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian dextromethorphan in United States include PRODOSE INC., SPIRIT PHARMACEUTICALS LLC, SHIELD PHARMACEUTICALS CORP., HEALTHLIFE OF USA LLC, REED - LANE INC, among 32 total buyers. The largest importer is PRODOSE INC., accounting for $559.6K USD across 10 shipments — representing 16% of all dextromethorphan imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PRODOSE INC. | 10 | $559.6K | 16.0% |
| 2 | SPIRIT PHARMACEUTICALS LLC | 8 | $380.2K | 10.9% |
| 3 | SHIELD PHARMACEUTICALS CORP. | 32 | $298.5K | 8.5% |
| 4 | HEALTHLIFE OF USA LLC | 6 | $233.0K | 6.7% |
| 5 | REED - LANE INC | 5 | $228.2K | 6.5% |
| 6 | XXROHXXLTHXXLC | 4 | $207.0K | 5.9% |
| 7 | SPIRIT PHARMACEUTICALS | 2 | $183.2K | 5.2% |
| 8 | OHM LABORATORIES INC. | 3 | $176.0K | 5.0% |
| 9 | SPIRIT PHARMACEUTICAL LLC | 3 | $139.7K | 4.0% |
| 10 | M s CONTINENTAL FORWARDING INC | 3 | $117.0K | 3.3% |
Showing top 10 of 32 Dextromethorphan importers in United States on this route.
Top 10 Dextromethorphan Formulations Imported by United States
Showing top 10 of 103 product formulations shipped on the India to United States Dextromethorphan route, ranked by trade value
United States imports a wide range of dextromethorphan formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — GUAIFENESIN & DEXTROMETHORPHAN HBR EXTEN — accounts for $207.0K USD across 4 shipments. There are 103 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GUAIFENESIN & DEXTROMETHORPHAN HBR EXTEN | 4 | $207.0K | 5.9% |
| 2 | Guaifenesin & Dextromethorphan HBR ER Tablet 1200/60 mg PACK : 14s Strip Batch :MHF0083B/MHF0095A/MHF0106A/MHF0129A/MHF | 3 | $176.0K | 5.0% |
| 3 | DEXTROMETHORPHAN HYDROBROMIDE CAPSULE 15MG 904 ANNEXURE A | 1 | $164.8K | 4.7% |
| 4 | ACETAMINOPHEN DEXTROMETHORPHAN HYDROBROMIDE DOXYLAMINE SUCCINATE &PHENYLEPHRINEHCL CAPSULE-907(ANNE.A DTLS ASPER INV.PC | 2 | $149.7K | 4.3% |
| 5 | ACETAMINOPHEN GUAIFENESIN DEXTROMETHORPHAN HYDROBROMIDE & PHENYLEPHRINE HCL CAPSULE-913 ,DTLS AS PER INV.& ANNEXURE C | 1 | $129.9K | 3.7% |
| 6 | ACETAMINOPHEN GUAIFENESIN DEXTROMETHORPHAN HYDROBROMIDE AND PHENYLEPHRINE HCL CAPSULES-913 | 1 | $117.9K | 3.4% |
| 7 | DAYTIME COLD AND FLU LIQUID GELS ACETAMINOPHEN 325MG DEXTROMETHORPHAN HYDROBROMIDE 10MG AND PHENYLEPHRINE HYDROCHLORID | 1 | $104.2K | 3.0% |
| 8 | GUAIFENESIN 1200MG AND DEXTROMETHORPHANHYDROBROMIDE 60MG ER TABLETS 1000'S | 7 | $101.1K | 2.9% |
| 9 | Acetaminophen USP 325mg,DextromethorphanHydrobromide USP 15mg, Doxylamine Succinate USP 6.25mg.B/N.OHS25048,(B/N AS PER | 2 | $95.6K | 2.7% |
| 10 | [REWARD ITEM] GUAIFENESIN 1200MG AND DEXTROMETHORPHAN HYDROBROMIDE 60MG ER TABLETS 1000'S | 1 | $94.8K | 2.7% |
Showing top 10 of 103 Dextromethorphan formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
DADRI ICD (INDER6) handles the highest volume with 20 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's dextromethorphan exports to United States are driven primarily by a handful of large-scale manufacturers. ELYSIUM PHARMACEUTICALS LTD with 20 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 22 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ELYSIUM PHARMACEUTICALS LTD, DR.REDDY'S LABORATORIES LTD, ELYSIUM PHARMACEUTICALS LIMITED — together account for 46% of total trade value on this route. The average shipment value of $24.4K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as guaifenesin & dextromethorphan hbr er tablet 1200/60 mg pack : 14s strip batch :mhf0083b/mhf0095a/mhf0106a/mhf0129a/mhf and dextromethorphan hydrobromide capsule 15mg 904 annexure a, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, PRODOSE INC. is the largest importer with 10 shipments worth $559.6K USD — representing 16% of all dextromethorphan imports from India on this route. A total of 32 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.5M
- Avg. Shipment
- $24.4K
- Suppliers
- 22
- Buyers
- 32
- Transit (Sea)
- ~25 days
- Annual Growth
- +22.2%
Related Analysis
Other Dextromethorphan Routes
Unlock the Full India to United States Dextromethorphan Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 143 shipments on this route.
Frequently Asked Questions — India to United States Dextromethorphan Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Dextromethorphan to United States?
The leading Indian exporters of Dextromethorphan to United States are ELYSIUM PHARMACEUTICALS LTD, DR.REDDY'S LABORATORIES LTD, ELYSIUM PHARMACEUTICALS LIMITED. ELYSIUM PHARMACEUTICALS LTD holds the largest market share at approximately 26% of total trade value on this route.
Q What is the total value of Dextromethorphan exports from India to United States?
India exports Dextromethorphan to United States worth approximately $3.5M USD across 143 recorded shipments. The average value per shipment is $24.4K USD.
Q Which ports does India use to ship Dextromethorphan to United States?
The most active port of origin is DADRI ICD (INDER6) with 20 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to United States for Dextromethorphan?
The average transit time for Dextromethorphan shipments from India to United States is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during July–September.
Q Is the India to United States Dextromethorphan trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 22.2% with demand growth tracking at 18.9%. The route is ranked #4 among India's top Dextromethorphan export destinations globally.
Q How many suppliers are active on the India to United States Dextromethorphan route?
There are currently 22 active Indian suppliers exporting Dextromethorphan to United States. The market is moderately concentrated with ELYSIUM PHARMACEUTICALS LTD accounting for 26% of total shipment value.
Q Who are the main importers of Dextromethorphan from India in United States?
The leading importers of Indian Dextromethorphan in United States include PRODOSE INC., SPIRIT PHARMACEUTICALS LLC, SHIELD PHARMACEUTICALS CORP., HEALTHLIFE OF USA LLC, REED - LANE INC. PRODOSE INC. is the largest buyer with 10 shipments worth $559.6K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Dextromethorphan.
- 2.Supplier/Buyer Matching: 22 Indian exporters and 32 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 143 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
143 Verified Shipments
22 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists